These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 37644281)
1. Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancer. Myers Chen KV; de Groot AE; Mendez SA; Mallin MM; Amend SR; Pienta KJ Med Oncol; 2023 Aug; 40(10):284. PubMed ID: 37644281 [TBL] [Abstract][Full Text] [Related]
2. Differential polarization and the expression of efferocytosis receptor MerTK on M1 and M2 macrophages isolated from coronary artery disease patients. Mohd Idrus FN; Ahmad NS; Hoe CH; Azlan M; Norfuad FA; Yusof Z; Wan Isa WYH; Mohamed Ali AA; Yvonne-Tee GB BMC Immunol; 2021 Mar; 22(1):21. PubMed ID: 33761885 [TBL] [Abstract][Full Text] [Related]
3. A+T rich interaction domain protein 3a (Arid3a) impairs Mertk-mediated efferocytosis in cholestasis. Chen R; Huang B; Lian M; Wei Y; Miao Q; Liang J; Ou Y; Liang X; Zhang H; Li Y; Xiao X; Wang Q; You Z; Chai J; Gershwin ME; Tang R; Ma X J Hepatol; 2023 Dec; 79(6):1478-1490. PubMed ID: 37659731 [TBL] [Abstract][Full Text] [Related]
4. MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression. Lin J; Xu A; Jin J; Zhang M; Lou J; Qian C; Zhu J; Wang Y; Yang Z; Li X; Yu W; Liu B; Tao H Oncoimmunology; 2022; 11(1):2024941. PubMed ID: 35036076 [TBL] [Abstract][Full Text] [Related]
5. MERTK tyrosine kinase receptor together with TIM4 phosphatidylserine receptor mediates distinct signal transduction pathways for efferocytosis and cell proliferation. Nishi C; Yanagihashi Y; Segawa K; Nagata S J Biol Chem; 2019 May; 294(18):7221-7230. PubMed ID: 30846565 [TBL] [Abstract][Full Text] [Related]
6. Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment. Myers KV; Amend SR; Pienta KJ Mol Cancer; 2019 May; 18(1):94. PubMed ID: 31088471 [TBL] [Abstract][Full Text] [Related]
7. Inhibiting efferocytosis reverses macrophage-mediated immunosuppression in the leukemia microenvironment. Cruz Cruz J; Allison KC; Page LS; Jenkins AJ; Wang X; Earp HS; Frye SV; Graham DK; Verneris MR; Lee-Sherick AB Front Immunol; 2023; 14():1146721. PubMed ID: 36960055 [TBL] [Abstract][Full Text] [Related]
8. Antibody Cross-Linking of CD14 Activates MerTK and Promotes Human Macrophage Clearance of Apoptotic Neutrophils: the Dual Role of CD14 at the Crossroads Between M1 and M2c Polarization. Zizzo G; Cohen PL Inflammation; 2018 Dec; 41(6):2206-2221. PubMed ID: 30091033 [TBL] [Abstract][Full Text] [Related]
9. Efferocytosis is restricted by axon guidance molecule EphA4 via ERK/Stat6/MERTK signaling following brain injury. Soliman E; Leonard J; Basso EKG; Gershenson I; Ju J; Mills J; de Jager C; Kaloss AM; Elhassanny M; Pereira D; Chen M; Wang X; Theus MH J Neuroinflammation; 2023 Nov; 20(1):256. PubMed ID: 37941008 [TBL] [Abstract][Full Text] [Related]
10. Polarization of prostate cancer-associated macrophages is induced by milk fat globule-EGF factor 8 (MFG-E8)-mediated efferocytosis. Soki FN; Koh AJ; Jones JD; Kim YW; Dai J; Keller ET; Pienta KJ; Atabai K; Roca H; McCauley LK J Biol Chem; 2014 Aug; 289(35):24560-72. PubMed ID: 25006249 [TBL] [Abstract][Full Text] [Related]
11. Elevated expression of macrophage MERTK exhibits profibrotic effects and results in defective regulation of efferocytosis function in pulmonary fibrosis. She Y; Xu X; Yu Q; Yang X; He J; Tang XX Respir Res; 2023 Apr; 24(1):118. PubMed ID: 37120511 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin II deteriorates advanced atherosclerosis by promoting MerTK cleavage and impairing efferocytosis through the AT Zhang Y; Wang Y; Zhou D; Zhang LS; Deng FX; Shu S; Wang LJ; Wu Y; Guo N; Zhou J; Yuan ZY Am J Physiol Cell Physiol; 2019 Oct; 317(4):C776-C787. PubMed ID: 31390228 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity. Nguyen KQ; Tsou WI; Calarese DA; Kimani SG; Singh S; Hsieh S; Liu Y; Lu B; Wu Y; Garforth SJ; Almo SC; Kotenko SV; Birge RB J Biol Chem; 2014 Sep; 289(37):25737-49. PubMed ID: 25074939 [TBL] [Abstract][Full Text] [Related]
15. Ligand-dependent kinase activity of MERTK drives efferocytosis in human iPSC-derived macrophages. Wanke F; Gutbier S; Rümmelin A; Steinberg M; Hughes LD; Koenen M; Komuczki J; Regan-Komito D; Wagage S; Hesselmann J; Thoma R; Brugger D; Christopeit T; Wang H; Point F; Hallet R; Ghosh S; Rothlin CV; Patsch C; Geering B Cell Death Dis; 2021 May; 12(6):538. PubMed ID: 34035216 [TBL] [Abstract][Full Text] [Related]
16. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice. Thorp E; Cui D; Schrijvers DM; Kuriakose G; Tabas I Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1421-8. PubMed ID: 18451332 [TBL] [Abstract][Full Text] [Related]
17. A Real-Time Image-Based Efferocytosis Assay for the Discovery of Functionally Inhibitory Anti-MerTK Antibodies. Bravo DD; Shi Y; Sheu A; Liang WC; Lin W; Wu Y; Yan M; Wang J J Immunol; 2023 Apr; 210(8):1166-1176. PubMed ID: 36881873 [TBL] [Abstract][Full Text] [Related]
18. Disturbed flow impairs MerTK-mediated efferocytosis in aortic endothelial cells during atherosclerosis. Wu J; Liu S; Banerjee O; Shi H; Xue B; Ding Z Theranostics; 2024; 14(6):2427-2441. PubMed ID: 38646649 [No Abstract] [Full Text] [Related]
19. Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactation. Sandahl M; Hunter DM; Strunk KE; Earp HS; Cook RS BMC Dev Biol; 2010 Dec; 10():122. PubMed ID: 21192804 [TBL] [Abstract][Full Text] [Related]
20. RNA-based modulation of macrophage-mediated efferocytosis potentiates antitumor immunity in colorectal cancer. Zhou X; Li D; Xia S; Ma X; Li R; Mu Y; Liu Z; Zhang L; Zhou Q; Zhuo W; Ding K; Lin A; Liu W; Liu X; Zhou T J Control Release; 2024 Feb; 366():128-141. PubMed ID: 38104775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]